Navigation Links
Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators,Published in Pediatrics

re published in Pediatrics. In addition, top-line results from Discovery Labs Phase 2 clinical trial for the prevention and treatment of BPD suggested that infants treated with up to five incremental standard doses of Surfaxin tended to have a lower incidence of death or BPD, a higher survival rate through 36 weeks post-menstrual age, and fewer days on mechanical ventilation.

About the medical journal, Pediatrics

Pediatrics, the official journal of the American Academy of Pediatrics, publishes papers on original research or observations and special feature articles in the field of pediatrics. Pediatrics serves as a medium for expression to the general medical profession as well as pediatricians. The Executive Board and Officers of the American Academy of Pediatrics select articles that appear in Pediatrics. The American Academy of Pediatrics is an organization of 60,000 primary care pediatricians, pediatric medical subspecialists, and pediatric surgical specialists dedicated to the health, safety, and well-being of infants, children, adolescents, and young adult. The Academy is committed to the attainment of optimal physical, mental, and social health for all infants, children, adolescents and young adults.

About Discovery Labs

Discovery Laboratories, Inc. is a biotechnology company developing Surfactant Replacement Therapies (SRT) for respiratory diseases. Surfactants are produced naturally in the lungs and are essential for breathing. Discovery Labs technology produces a precision-engineered surfactant that is designed to closely mimic the essential properties of natural human lung surfactant. Discovery Labs believes that its proprietary SRT pipeline has the potential to advance respiratory medicine and address a variety of respiratory diseases affecting neonatal, pediatric and adult patients.

Discovery Labs lead product candidate, Surfaxin(r), is the subject of an Approvable Letter from the FDA for the prevention of Respiratory
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric Academic Societies Annual Meeting
2. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
3. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
4. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
5. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
6. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
7. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
8. UCB Presents Long-Term CImzia Data in Crohns Disease
9. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
10. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
11. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
Post Your Comments:
(Date:10/17/2014)... Research ... addition of the  "China Interventional Cardiovascular Device ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The ... China impacted by accelerated aging ... dietary habit, way of working and other ...
(Date:10/17/2014)... , October 17, 2014 Investor-Edge ... Inc. (NASDAQ: ARNA ), NPS Pharmaceuticals Inc. ... XOMA ), Momenta Pharmaceuticals Inc. (NASDAQ: ... Free research on these five companies can be accessed ... on Thursday, October 16, 2014, ended on a mixed ...
(Date:10/17/2014)... SM , the nation,s leader in medication monitoring solutions, ... M.D., as Chief Medical Officer. In this role, Smith ... healthcare providers, patients and managed care plans.   ... of healthcare companies that have provided him with experiences ... sides of Ameritox,s business. He most recently served as ...
Breaking Medicine Technology:China Interventional Cardiovascular Device Industry Report 2014-2017 2China Interventional Cardiovascular Device Industry Report 2014-2017 3Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 2Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 3Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 4Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 5Ameritox Appoints New Chief Medical Officer 2
... Musculoskeletal Transplant Foundation (MTF) has announced the release of two ... The new sizes--16cm x 20cm and 20cm x 20cm--are being ... their patients. This unique human dermal allograft is specifically prepared ... has been a year since MTF introduced its bi-lateral breast ...
... -- Lotus Pharmaceuticals, Inc. (OTCBB: LTUS) ("Lotus" or the ... and drugs in the People,s Republic of China ("PRC"), ... its Inner Mongolia branch company, including land use right ... Inner Mongolia, in order to focus its business on ...
Cached Medicine Technology:New, Larger, Bilateral Breast Graft Kits Announced by MTF 2Lotus Pharmaceuticals Announces Business Reorganization and Provides Updates on the Beijing Headquarters Building 2Lotus Pharmaceuticals Announces Business Reorganization and Provides Updates on the Beijing Headquarters Building 3
(Date:10/20/2014)... October 20, 2014 The Advocator ... booth at the American Foundation for Suicide Prevention’s (AFSP) ... AFSP is a not-for-profit organization that hosts hundreds of ... from these events are used to help understand and ... and personal relationships as well. , The Advocator ...
(Date:10/20/2014)... Zereana Jess-Huff, a 34-year-old mother, corporate executive and ... platform to think outside the bra. She doesn’t try to ... raise awareness about women’s other lady parts. , "We have ... the color pink and everybody knows what you’re talking about,” ... it has not been won when it comes to gynecologic ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 ... Voicheck as Assistant Director of their CentralSource ... in managing the innovative turnkey drug sourcing, distribution, ... Matthew brings over 12 years of industry experience, ... Myoderm at the peak of their international success ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Final Cut Pro ... release of the Citrus theme for FCPX filmmakers . ... use to describe the Citrus theme” Says Christina Austin, CEO ... to look so professional.” , Citrus comes with all the ... the template are: four transitions for added style, a title ...
(Date:10/20/2014)... 2014 Do you ever feel difficulty ... a wonderful app Metassessor for teachers, specialists and parents. ... helped its client “Intervention Development LLC” to launch Metassessor ... designed for iOS 4.3 or later and is Compatible ... optimized for iPhone 5. It is now available on ...
Breaking Medicine News(10 mins):Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3
... campaign targets push towards cultural changes that promote ... a leading developer of technology for the safe ... the launch of a targeted campaign recognizing patient ... is intended to emphasize the need for a ...
... VIEW, Calif., March 10 IRIDEX Corporation (Nasdaq: ... quarter and full fiscal year ended January 3, 2009.Revenues for ... decrease from the $14.1 million reported for the fourth quarter ... or $0.74 per diluted share for the fourth quarter of ...
... in America, and many old people themselves trade in unflattering ... are not only false and cruel, they are also unhealthy. ... age stereotypes tend to fulfill them. , And it may ... A new study in Psychological Science , a journal ...
... host seminar Tuesday, March 17, 2009, from 8:30 to 9:30 ... the leading expert in ion channels and GPCRs (G-protein coupled ... will feature the latest in its expanding line of services ... conference March 15-19, in Baltimore, Maryland. ChanTest,s growing catalog, comprising ...
... to Mount For Strawberry Nutrition BenefitsWATSONVILLE, Calif., March 10 ... of super foods that improve health and ... on time. A new study published in the scientific ... in strawberries help lower "bad" cholesterol.The study, conducted by ...
... March 10 Stamford-based Olympus Partners is pleased ... Corp. from The Hansen Corporate Group. Holopack ... its name to The Ritedose Corporation (TRC).TRC is ... United States. In the BFS process, a ...
Cached Medicine News:Health News:Baxa Corporation Launches 'Culture of Safety' Campaign to Recognize National Patient Safety Awareness Week 2Health News:Baxa Corporation Launches 'Culture of Safety' Campaign to Recognize National Patient Safety Awareness Week 3Health News:IRIDEX Reports Fourth Quarter and Full Year 2008 Financial Results 2Health News:IRIDEX Reports Fourth Quarter and Full Year 2008 Financial Results 3Health News:IRIDEX Reports Fourth Quarter and Full Year 2008 Financial Results 4Health News:IRIDEX Reports Fourth Quarter and Full Year 2008 Financial Results 5Health News:IRIDEX Reports Fourth Quarter and Full Year 2008 Financial Results 6Health News:IRIDEX Reports Fourth Quarter and Full Year 2008 Financial Results 7Health News:IRIDEX Reports Fourth Quarter and Full Year 2008 Financial Results 8Health News:The perils of ageism 2Health News:ChanTest to Highlight Expanded Ion Channel and GPCR Services and Cell Lines, Including FDA Critical Path Safety Profiling Tools at ToxExpo, Booth 3056 2Health News:ChanTest to Highlight Expanded Ion Channel and GPCR Services and Cell Lines, Including FDA Critical Path Safety Profiling Tools at ToxExpo, Booth 3056 3Health News:Spoonfuls of Strawberries Help the Cholesterol Go Down 2Health News:Spoonfuls of Strawberries Help the Cholesterol Go Down 3
... brightest and most versatile light source Luxtec ... Watts, this unique light source allows to ... illuminated instrument or two UltraLite Headlights at ... bright, white light that is as close ...
Loupe KS is achieved by a special system carrier....
... magnification for advanced surgical procedures. Prismatic quality ... the highest magnification. 3.5x, 4.5x and 5.5x. ... rendition is ideal for surgical applications. Precision ... a superior image. The compact abd lightweight ...
... magnification for advanced surgical procedures. Prismatic quality ... the highest magnification. 3.5x, 4.5x and 5.5x. ... rendition is ideal for surgical applications. Precision ... a superior image. The compact abd lightweight ...
Medicine Products: